PRISM (E11 Bio) - Bryant McGill

# PRISM (E11 Bio) **Publication-canonical expansion:** Protein-barcode Reconstruction via Iterative Staining with Molecular annotations **Documented variant:** Protein-barcode Reconstruction by Iterative Staining with Molecular annotations **Entity class:** Identity-preserving optical-connectomics platform **Collections:** [[collections/Neurotech|Neurotech]] · [[collections/Consciousness Continuity|Consciousness Continuity]] **Canonical source articles:** [[articles/Technologies for Consciousness Mapping and Transfer|Technologies for Consciousness Mapping and Transfer]] · [[articles/The Organic-Synthetic Brain Atlas|The Organic-Synthetic Brain Atlas]] · [[articles/Mind Uploading and AI — The Host is Reusable and the Person is the Delta|Mind Uploading and AI — The Host is Reusable and the Person is the Delta]] ## Definition **PRISM** is an optical neuron-reconstruction platform developed by [[wiki/E11 Bio|E11 Bio]] with collaborating investigators. It gives neurons combinatorial, machine-readable protein identities and preserves those identities through an expanded tissue volume. The September 28, 2025 bioRxiv preprint defines the name as **Protein-barcode Reconstruction via Iterative Staining with Molecular annotations**. E11's December 2024 roadmap and [[wiki/Addgene|Addgene]] use **by** rather than **via**; that is a documented naming variant, not the publication-canonical form. The platform addresses a specific failure mode in [[wiki/Connectomics|connectomics]]. Thin, branching neurites are difficult to follow where cells cross, signal weakens, sections are damaged, or image data contain gaps. Conventional segmentation must infer continuity mainly from morphology. PRISM supplies a second evidentiary channel: a distributed protein barcode that fills the cell and can be read along its axons and dendrites. Morphology and identity can therefore cross-check one another. PRISM is an end-to-end measurement-and-reconstruction architecture, not only a wet-lab label. Neurons are genetically assigned stochastic combinations of antigenically distinct, cell-filling protein “bits.” Tissue is physically enlarged, repeatedly stained, imaged, stripped, and restained. The cycles are spatially registered, and machine-learning models combine shape with barcode information to segment neurites, identify inconsistent assignments, reconnect compatible fragments, and register molecular or synaptic markers onto the reconstructed morphology. In information terms, biological identity is converted into a spatially distributed signal that remains available where morphology alone becomes ambiguous. ## Demonstrated result and publication status The controlling scientific record is the September 28, 2025 bioRxiv preprint, **“[[wiki/Combinatorial protein barcodes enable self-correcting neuron tracing with nanoscale molecular context|Combinatorial protein barcodes enable self-correcting neuron tracing with nanoscale molecular context]].”** It is a preprint and has not been peer reviewed. The pilot covered approximately **10 million cubic micrometres** of mouse hippocampal area CA2/3 and multiplexed **23 channels**: 18 barcode antigens and five synaptic markers. The paper reports more than a **750-fold increase in label diversity** over prior multicolor labeling and an **eightfold increase in automatic tracing accuracy** when barcode information and automatic proofreading are combined with shape-based segmentation. It also demonstrates automatic proofreading across micron-scale signal gaps, reconnection across discontinuities extending hundreds of micrometres, synapse mapping, and analysis of thorny excrescences. Those findings do not establish perfect or error-free reconstruction. The defensible descriptions are **self-correcting**, **automatic proofreading**, and **intrinsic error correction**. Barcode collisions, expression variability, segmentation errors, sample defects, registration error, and the need for human review remain relevant. The approximately **35 × 35 × 80 nm** measurements are effective voxel dimensions in the expanded dataset; voxel sampling and optical resolving power are not synonyms. ## Protein-barcode code space The demonstrated system used **18 protein bits**, giving a theoretical nonzero binary code space of $2^{18}-1 = 262{,}143$. This number is not the count of barcodes guaranteed to occur or remain unique in arbitrarily large populations. E11 reports stochastic expression in which most sampled neurons expressed several bits, while observed uniqueness depended on expression probabilities and collisions. [[wiki/Addgene|Addgene]] conservatively describes the collection as producing more than 100,000 detectable combinations. The distinction among **theoretical code space**, **experimental occupancy**, and **usable diversity** is essential. PRISM's advance is not merely “more colors.” Its protein bits fill neuronal morphology, so the identity signal is present along processes where sequencing-only identifiers do not by themselves supply a continuous segmentation channel. ## Institutional form and chronology [[wiki/E11 Bio|E11 Bio]] is a nonprofit [[wiki/Focused Research Organization|Focused Research Organization]] supported by [[wiki/Convergent Research|Convergent Research]]. Convergent describes FROs as startup-like, time-bounded nonprofit teams built for engineering-heavy scientific bottlenecks that fall awkwardly between university laboratories, venture-backed companies, corporate R&D, and conventional government programs. Its current model describes teams of roughly 10–30 or more people, initial grants of $20–50 million, three-to-seven-year operating horizons, pre-launch incubation, and post-launch governance and operational support. The institutional chronology contains a real source difference. Convergent says E11 was **established in 2021**; E11 says it was **launched in 2022**. These may describe different organizational milestones, but no source presently establishes that interpretation. Both dates are therefore retained with their source language rather than collapsed into a single founding date. The FRO relationship also has a documented intellectual prehistory. [[wiki/Sam Rodriques|Sam Rodriques]] and [[wiki/Adam Marblestone|Adam Marblestone]] published a September 2020 proposal for independent, startup-like organizations able to execute coordinated scientific projects that conventional academic and commercial incentives underserve. Convergent later institutionalized the FRO form; E11 operates within that form; and Rodriques later helped conceptualize, develop early methods for, write, and supervise the PRISM study. This is an institutional genealogy and recursion, not evidence that Rodriques controls Convergent or E11. ## People, laboratory lineages, and technical contributions The formal author-contribution statement is controlling for individual work assignments. **[[wiki/Andrew C. Payne|Andrew C. Payne]]** is E11's co-founder and CEO. His earlier MIT research joined DNA sequencing to spatial imaging, giving him a direct technical path from spatial genomics into connectomics. For PRISM, the contribution statement credits him with conceptualization, early-method development, manuscript preparation, supervision, and correspondence. **[[wiki/Jun Axup Penman|Jun Axup Penman]]** is E11's co-founder and COO and a chemical biologist with experience in unnatural amino acids, immuno-oncology, protein engineering, lab automation, CRISPR, and multiplex proteomics. The paper credits Axup, [[wiki/Stephanie Chan|Stephanie Chan]], [[wiki/Kathleen G. C. Leeper|Kathleen Leeper]], and [[wiki/Michelle Wu|Michelle Wu]] with designing, cloning, and testing the C-terminal eGFP barcode system. **[[wiki/Sung Yun Park|Sung Yun “Rosa” Park]]** and **[[wiki/Arlo Sheridan|Arlo Sheridan]]** are co-first authors. Park was jointly affiliated with E11 Bio and the [[wiki/Francis Crick Institute|Francis Crick Institute]]. She contributed to conceptualization and early methods, co-developed the iterative [[wiki/MAGNIFY|MAGNIFY]] protocol with [[wiki/Sven Truckenbrodt|Sven Truckenbrodt]], screened compatible antibodies, imaged the hippocampal dataset, participated in registration and writing, and is listed as an inventor on the related patent application. Sheridan came through [[wiki/Jan Funke|Jan Funke]]'s computational-connectomics lineage at [[wiki/Janelia Research Campus|Janelia]], including [[wiki/Local Shape Descriptors|Local Shape Descriptors]]. Sheridan and [[wiki/William Patton|William Patton]] developed both barcode-augmented segmentation and barcode-augmented automatic proofreading; Sheridan also participated in synapse detection and analysis. **William Patton** and **Sven Truckenbrodt** are core architectural contributors, not incidental names in the author list. Patton shares direct credit for the segmentation and proofreading systems and co-authors [[wiki/Volara|Volara]] with Sheridan. Truckenbrodt co-developed the iterative MAGNIFY protocol, screened antibodies, registered the volume, helped write the manuscript, and is named on the patent application. **[[wiki/Johan Winnubst|Johan Winnubst]]** is E11's co-founder and lead scientist for neuroanatomy. His earlier work as principal scientist on [[wiki/MouseLight|MouseLight]] helped reconstruct more than 1,000 whole-brain projection neurons. In PRISM he developed the stitching and registration pipeline and participated in volume registration, writing, synapse detection, and synaptic analysis. **[[wiki/Kathleen G. C. Leeper|Kathleen G. C. Leeper]]** is E11's co-founder and lead scientist for barcoding. Her trajectory links [[wiki/George Church|George Church]]'s spatial transcriptomics and CRISPR-lineage work, [[wiki/Reza Kalhor|Reza Kalhor]]'s genomic recording work, and E11's protein-barcode architecture. The PRISM paper credits her across conceptualization, barcode-system design and characterization, registration, and writing. **[[wiki/Ed Boyden|Edward S. Boyden]]** is an enabling-technology contributor, not a celebrity attachment. His MIT laboratory introduced [[wiki/Expansion Microscopy|expansion microscopy]], the principle on which PRISM's physical enlargement and nanoscale optical interrogation depend. The paper credits him with conceptualization, writing, supervision, and correspondence. PRISM did not invent MAGNIFY; Park and Truckenbrodt developed an iterative MAGNIFY protocol for this workflow. **[[wiki/Joergen Kornfeld|Joergen M. R. Kornfeld]]** studies how learned behavior relates to synaptic wiring and is establishing a Connectomics of Learned Behaviour group at the [[wiki/MRC Laboratory of Molecular Biology|MRC Laboratory of Molecular Biology]] while remaining connected to the [[wiki/Max Planck Institute for Biological Intelligence|Max Planck Institute for Biological Intelligence]]. He contributed to PRISM conceptualization, early methods, and supervision. This directly intersects a wiring-reconstruction technology with a program studying learned information in connectivity; it does not show that PRISM reads memories, personality, or consciousness. **[[wiki/George Church|George M. Church]]** and **[[wiki/Jan Funke|Jan Funke]]** contributed to conceptualization. Church's relevant lineage runs through genomics, molecular multiplexing, spatial measurement, and [[wiki/FISSEQ|FISSEQ]], and E11 lists him as a scientific adviser. Funke's relevant lineage runs through scalable connectomic segmentation and Sheridan's Local Shape Descriptor work. The hands-on barcode segmentation and proofreading work remains assigned to Sheridan and Patton rather than to Funke. **[[wiki/Sam Rodriques|Samuel G. Rodriques]]** links platform science to institutional design. After the 2020 FRO proposal, he led an Applied Biotechnology laboratory at the Francis Crick Institute and co-founded [[wiki/FutureHouse|FutureHouse]] with Andrew White in 2023 to build AI systems for scientific discovery. FutureHouse later separated commercial deployment into [[wiki/Edison Scientific|Edison Scientific]]. The organizations have distinct missions and governance; the shared founder and conceptual trajectory do not establish common ownership or control with E11 or Convergent. ## Technical ancestry PRISM converges several independently documented lineages: - **Combinatorial optical identity:** [[wiki/Brainbow|Brainbow]] and related multicolor labeling showed that stochastic combinations of fluorescent proteins can distinguish neighboring neurons, but the resolvable color palette is limited. - **Nucleic-acid identity:** [[wiki/MAPseq|MAPseq]] and [[wiki/BARseq|BARseq]] use sequence barcodes for high-throughput projection mapping. Their enormous identity spaces do not by themselves provide PRISM's continuously cell-filling protein morphology. - **Spatial molecular measurement:** [[wiki/FISSEQ|FISSEQ]] and spatial genomics preserve molecular identity at spatial coordinates and form part of the Church–Leeper lineage. - **Long-range morphology:** [[wiki/MouseLight|MouseLight]] established a workflow for whole-brain projection-neuron reconstruction and supplies Winnubst's neuroanatomical lineage. - **Physical resolution:** Boyden's expansion microscopy and the later MAGNIFY anchoring chemistry physically separate retained molecules for conventional optical imaging. Park and Truckenbrodt adapted an iterative MAGNIFY workflow for PRISM. - **Computational segmentation:** affinity prediction, Local Shape Descriptors, large-volume block processing, and [[wiki/Machine Learning Segmentation|machine-learning segmentation]] supply the reconstruction lineage. PRISM adds an identity code to the object being segmented so identity and morphology can test one another. - **Multiplexed readout:** [[wiki/Iterative Molecular Staining|iterative molecular staining]] permits repeated protein-bit and endogenous-marker measurement in the same registered specimen. ## Open science, software, data, and intellectual property PRISM combines a public-goods distribution model with a documented patent family. [[wiki/Addgene|Addgene]] distributes E11's PRISM plasmids. E11 releases [[wiki/Volara|Volara]] and model-training resources, presents interactive volumes through [[wiki/Neuroglancer|Neuroglancer]], and exposes raw images, segmentations, predictions, annotations, and training data through the [[wiki/E11 Bio PRISM Open Data|E11 Bio PRISM Open Data]] record on AWS. The patent family represented by **[[wiki/WO2025106572A1|WO2025106572A1]]** has a November 14, 2023 priority date, a November 13, 2024 filing date, and a May 22, 2025 publication date. The listed inventors are Andrew C. Payne, Kathleen G. C. Leeper, Sven M. Truckenbrodt, Sung Yun Park, Samuel G. Rodriques, and Julia M. Michalska; E11 Bio LLC is the listed assignee. The record describes fusion proteins with distinguishable peptide epitopes and iterative detection in mammalian neural tissue. The `LLC` assignee name is a patent/legal-entity field and does not by itself contradict E11's public description as a nonprofit FRO. Volara provides block-wise operations for arbitrarily large multidimensional microscopy volumes. The released PRISM training stack identifies models for barcode-signal enhancement, affinities and Local Shape Descriptors, uniform embedding, barcode-expression inference, and synapse detection. Together with registration, graph clustering, block processing, proofreading, and Neuroglancer visualization, these resources make PRISM an acquisition-and-reconstruction stack rather than a single assay. ## External recognition and scaling boundary Nature's January 2026 feature selected **light-microscopy brain mapping** as one of seven technologies to watch and discussed E11's protein-barcode work and the PRISM preprint within that category. It did not independently designate PRISM itself as one of seven technologies. The feature also treated sample handling and imaging speed as remaining scale constraints. Whole-brain mapping, brain simulation, NeuroAI, therapeutics, and BCI are E11 roadmap targets, not demonstrated outcomes of the 2025 pilot. The published experiment is an approximately 10-million-µm³ mouse hippocampal volume, not a whole mouse brain and not a human connectome. Cost, whole-brain timing, and scale forecasts remain dated developer claims pending independent replication at larger volumes. ## Continuity relevance and boundary PRISM is relevant to the acquisition layer of the continuity corpus because it reduces one genuine source of structural information loss: the inability to preserve neuronal identity while very thin processes traverse long distances, overlap other cells, weaken, or cross missing data. If future person-specific continuity systems require sufficiently faithful acquisition of an individual's connectomic organization, identity-preserving, molecularly annotated, automatically proofread methods of this class could become important inputs. PRISM does **not** upload minds, extract autobiographical memories, reconstruct consciousness, capture the complete dynamical state of a brain, establish that a static connectome is sufficient for personal identity, or resolve [[wiki/State Sufficiency Problem|the State Sufficiency Problem]]. Its demonstrated contribution is narrower and still substantial: it adds a molecular identity signal that can reduce structural reconstruction error in a possible future chain from biological circuitry to machine-readable representation. ## Relationships - **Developed by:** [[wiki/E11 Bio|E11 Bio]], a [[wiki/Focused Research Organization|Focused Research Organization]] supported by [[wiki/Convergent Research|Convergent Research]]. - **Direct paper contribution:** [[wiki/Sung Yun Park|Sung Yun Park]], [[wiki/Arlo Sheridan|Arlo Sheridan]], [[wiki/William Patton|William Patton]], [[wiki/Sven Truckenbrodt|Sven Truckenbrodt]], [[wiki/Johan Winnubst|Johan Winnubst]], [[wiki/Kathleen G. C. Leeper|Kathleen G. C. Leeper]], [[wiki/Jun Axup Penman|Jun Axup Penman]], [[wiki/Andrew C. Payne|Andrew C. Payne]], [[wiki/Ed Boyden|Ed Boyden]], [[wiki/Joergen Kornfeld|Joergen Kornfeld]], [[wiki/Sam Rodriques|Sam Rodriques]], [[wiki/George Church|George Church]], and [[wiki/Jan Funke|Jan Funke]], with specific work assignments preserved above. - **Institutional affiliation:** [[wiki/Francis Crick Institute|Francis Crick Institute]], [[wiki/MIT|MIT]], [[wiki/Howard Hughes Medical Institute|HHMI]], [[wiki/Janelia Research Campus|Janelia]], [[wiki/Max Planck Institute for Biological Intelligence|Max Planck Institute for Biological Intelligence]], and [[wiki/MRC Laboratory of Molecular Biology|MRC Laboratory of Molecular Biology]]. - **Enabling technology:** [[wiki/Protein Barcoding|protein barcoding]], [[wiki/Expansion Microscopy|expansion microscopy]], [[wiki/MAGNIFY|MAGNIFY]], [[wiki/Iterative Molecular Staining|iterative staining]], [[wiki/Machine Learning Segmentation|machine-learning segmentation]], and [[wiki/Local Shape Descriptors|Local Shape Descriptors]]. - **Technical ancestry:** [[wiki/Brainbow|Brainbow]], [[wiki/MAPseq|MAPseq]], [[wiki/BARseq|BARseq]], [[wiki/FISSEQ|FISSEQ]], and [[wiki/MouseLight|MouseLight]]. - **Open infrastructure:** [[wiki/Addgene|Addgene]], [[wiki/Volara|Volara]], [[wiki/E11 Bio PRISM Open Data|E11 Bio PRISM Open Data]], and [[wiki/Neuroglancer|Neuroglancer]]. - **Intellectual property:** [[wiki/WO2025106572A1|WO2025106572A1]]. Patent inventorship, paper authorship, advisory work, and organizational control remain separate relationship types. - **Acronym boundary:** [[wiki/PRISM|the PRISM index]] keeps this platform separate from [[wiki/PRISM (NSA)|the NSA program]] and [[wiki/PRISM (Partnership for Research Into Sentient Machines)|the digital-minds charity]]. - **Continuity interpretation:** [[articles/Technologies for Consciousness Mapping and Transfer|Technologies for Consciousness Mapping and Transfer]], [[articles/The Organic-Synthetic Brain Atlas|The Organic-Synthetic Brain Atlas]], and [[articles/Mind Uploading and AI — The Host is Reusable and the Person is the Delta|Mind Uploading and AI — The Host is Reusable and the Person is the Delta]]. - **Collection route:** [[collections/Neurotech|Neurotech]]. ## Research edges and provenance - **Directly demonstrated — primary preprint:** platform definition, pilot volume, channel count, code-space description, automatic-tracing results, gap bridging, molecular annotation, thorny-excrescence analysis, formal affiliations, and author contributions. - **Officially claimed — developer and institutional records:** E11's whole-brain, cost, NeuroAI, simulation, therapeutics, and BCI roadmaps; E11's 2022 launch language; Convergent's 2021 establishment language and FRO operating model. - **Historically documented — original publications and repositories:** expansion microscopy, MAGNIFY, Brainbow, MAPseq, BARseq, FISSEQ, MouseLight, Local Shape Descriptors, Volara, and the September 2020 FRO proposal. - **Intellectual-property relationship — patent record:** priority, filing, publication, inventor, assignee, and molecular-architecture fields for WO2025106572A1. - **Analytically inferred — continuity relevance:** identity-preserving acquisition reduces one structural information-loss mode. It does not establish memory recovery, consciousness reconstruction, or personal continuity. ## Naming and metadata conflicts - **Publication-canonical:** *Protein-barcode Reconstruction via Iterative Staining with Molecular annotations* — bioRxiv/PMC preprint. - **Documented variant:** *Protein-barcode Reconstruction by Iterative Staining with Molecular annotations* — E11's 2024 roadmap and Addgene. - **Conflicting registry metadata:** *Protein Reconstruction and Identification through Multiplexing* — AWS Open Data and an E11 training-repository description. This is recorded as a discrepancy, not promoted to a canonical synonym. - **Excluded:** *Photo-connectomic Reconstruction by Iterative Staining with Molecular annotations*. No verified E11 source in this review establishes it as the same project's expansion. ## Sources - [bioRxiv — Combinatorial protein barcodes enable self-correcting neuron tracing with nanoscale molecular context](https://doi.org/10.1101/2025.09.26.678648) - [PubMed Central — full preprint record and author-contribution statement](https://pmc.ncbi.nlm.nih.gov/articles/PMC12485930/) - [E11 Bio — PRISM release, 1 October 2025](https://www.e11.bio/blog/prism) - [E11 Bio — roadmap, 3 December 2024](https://www.e11.bio/blog/roadmap) - [E11 Bio — Focused Research Organization](https://www.e11.bio/fro) - [Addgene — E11 Bio PRISM Collection](https://www.addgene.org/depositor-collections/e11-bio-prism-collection/) - [Convergent Research — E11 Bio](https://www.convergentresearch.org/ecosystem/e11-bio) - [Convergent Research — About FROs](https://www.convergentresearch.org/about-fros) - [Federation of American Scientists — Focused Research Organizations proposal, September 2020](https://fas.org/publication/focused-research-organizations-to-accelerate-science-technology-and-medicine/) - [AWS Registry of Open Data — E11bio PRISM](https://registry.opendata.aws/e11bio-prism/) - [GitHub — e11bio/volara](https://github.com/e11bio/volara) - [Google Patents — WO2025106572A1](https://patents.google.com/patent/WO2025106572A1/en) - [Nature — Seven technologies to watch in 2026](https://www.nature.com/articles/d41586-026-00188-6) ## Research Inferences  These entries translate the forward-looking register in [[research/Research Inferences|Research Inferences]] into ordinary wiki prose. The tier labels apply to the inference, not automatically to every factual anchor inside it. The interpretive frame comes from [[articles/Technologies for Consciousness Mapping and Transfer|Technologies for Consciousness Mapping and Transfer]] and [[articles/Mind Uploading and AI — The Host is Reusable and the Person is the Delta|Mind Uploading and AI — The Host is Reusable and the Person is the Delta]]. Collection route: [[collections/Neurotech|Neurotech]]. - **INF-0101 — Developer projection with demonstrated subsystem.** PRISM combines protein barcoding, expansion microscopy, iterative molecular staining, and learned reconstruction as an optical alternative to parts of the electron-microscopy path. E11 projects an aggregate 100× cost reduction; the demonstrated record is the 2025 mouse-hippocampal pilot, not whole-brain cost validation.  ## Quotations  Quotations here are evidence for named propositions, not substitutes for proof. Confidence grades describe the quotation's provenance; they do not raise the associated scientific or philosophical inference to the same tier. The selection record is [[research/Research Inferences|Research Inferences]] and the supplied quotation review dated 2026-09-11. > “even simulating our own brain circuitry.” > > — **Andrew C. Payne**, 2024 E11 Bio roadmap. [Source](https://www.e11.bio/blog/roadmap) · **Provenance confidence:** High **Evidentiary role:** articulates E11's downstream simulation horizon; it is not a claim that PRISM already performs emulation. > “build safe, brain-inspired AI, and simulate brains” > > — **Andrew C. Payne, Arlo Sheridan, Kathleen G. C. Leeper, and Johan Winnubst**, 2025 E11 Bio PRISM release. [Source](https://www.e11.bio/blog/prism) · **Provenance confidence:** High **Evidentiary role:** states the institutional motivation for detailed wiring maps while leaving demonstrated capability narrower.  ## Research Inference Attractors  These are secondary semantic placements for the inference attractor network. Each statement keeps its original ID and tier; its canonical cluster page links back to every destination. Source register: [[research/Research Inferences|Research Inferences]]. Interpretive context: [[articles/Technologies for Consciousness Mapping and Transfer|Technologies for Consciousness Mapping and Transfer]] and [[articles/Mind Uploading and AI — The Host is Reusable and the Person is the Delta|Mind Uploading and AI — The Host is Reusable and the Person is the Delta]]. Collection route: [[collections/Neurotech|Neurotech]]. - **INF-0102 — Established.** Comprehensively tracing roughly 1,500 mouse neurons required years of human revision and over a million manual corrections, which places proofreading above 95% of project cost. Whole-brain connectomics is therefore a labor-automation problem wearing a microscopy costume. - **Canonical cluster:** [[wiki/Connectomics|Connectomics]] - **INF-0103 — Strongly indicated.** GPU-accelerated segmentation cutting reconstruction cost 10–100× means the connectome timeline is now indexed to accelerator availability. Every improvement in datacenter capacity shortens the schedule for mapping a mammalian brain, which couples neuroscience directly to the AI capital cycle. - **Canonical cluster:** [[wiki/Connectomics|Connectomics]] - **INF-0109 — Plausible.** Iterative staining attaches molecular identity to each traced process, so the resulting map carries cell type and receptor complement rather than geometry alone. A typed connectome is directly simulable in a way a geometric one is not, because the parameters come with it. - **Canonical cluster:** [[wiki/Connectomics|Connectomics]] - **INF-0112 — Established.** Losing or damaging ultra-thin sections fragments a dataset into discontinuous chunks, and no group has traced neurons through even a millimeter of sliced tissue in all three axes. Mechanical handling, not imaging, is the unglamorous constraint on long-range connectivity. - **Canonical cluster:** [[wiki/Connectomics|Connectomics]] - **INF-0121 — Established.** The PRISM collaboration spans the Crick Institute, Max Planck/LMB Cambridge, MIT, and HHMI under a philanthropically funded nonprofit. Nonprofit structure means the method is published rather than licensed, which accelerates diffusion and removes the usual private bottleneck. - **Canonical cluster:** [[wiki/Connectomics|Connectomics]]